Angiotensin-converting enzyme 2 gene expression in human male urological tissues: implications for pathogenesis and virus transmission pathways

Angiotensin-converting enzyme 2 gene expression in human male urological tissues: implications for pathogenesis and virus transmission pathways

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection occurs through binding and internalization of the viral spike protein to the angiotensin-converting enzyme 2 (ACE2) receptor on the host cell membrane. Pathological changes are caused by damage and failure of...

Full description

Bibliographic Details
Main Author:	Sammy Al-Benna
Format:	Article
Language:	English
Published:	SpringerOpen 2021-07-01
Series:	African Journal of Urology
Subjects:	Urology Genitalia Male Angiotensin-converting enzyme 2 receptor Coronavirus Severe acute respiratory syndrome coronavirus 2
Online Access:	https://doi.org/10.1186/s12301-021-00192-4

Similar Items

Angiotensin-Converting Enzyme 2 in the Pathogenesis of Renal Abnormalities Observed in COVID-19 Patients
by: Nayara Azinheira Nobrega Cruz, et al.
Published: (2021-08-01)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
by: Meng-Yuan Liu, et al.
Published: (2020-06-01)

Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials
by: Nicolás Meza, et al.
Published: (2021-03-01)

Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
by: Sang Heon Suh, et al.
Published: (2021-03-01)

Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin-Converting Enzyme 2 Correlates With Renin and Body Mass Index
by: Lars Jehpsson, et al.
Published: (2021-01-01)

Biochemical parameters and pathogenesis of SARS-CoV-2 infection in vital organs: COVID-19 outbreak in Iran
by: S. Mirmohammadi, et al.
Published: (2020-11-01)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021-08-01)

A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
by: Amanj Kurdi, et al.
Published: (2020-12-01)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
by: Brini, M., et al.
Published: (2022)

Impact of COVID-19 on Clinical and Academic Urological Practice: A Survey from European Association of Urology Section of Uro-technology
by: Alexander Heinze, et al.
Published: (2020-10-01)

Recent advance of ACE2 and microbiota dysfunction in COVID-19 pathogenesis
by: Zhidan Yu, et al.
Published: (2021-07-01)

Angiotensin-converting enzyme 2. Approaches to pathogenetic therapy of COVID-19
by: Polina O. Shatunova, et al.
Published: (2020-09-01)

Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth
by: Kunal Bikram Shaha, et al.
Published: (2020-05-01)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
by: Qiyue Ding, et al.
Published: (2021-02-01)

Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk
by: Zeinab Imani-Saber, et al.
Published: (2020-10-01)

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
by: Daniel Caldeira, et al.
Published: (2020-12-01)

Exploring the causes of mild COVID-19 involvement in pediatric patients
by: A. Naserghandi, et al.
Published: (2020-09-01)

COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice
by: Cathleen Lutz, et al.
Published: (2020-06-01)

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019
by: Mudasir S. Andrabi, et al.
Published: (2020-11-01)

Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019
by: Chunsheng Zhu, et al.
Published: (2020-08-01)

Underlying Mechanisms and Candidate Drugs for COVID-19 Based on the Connectivity Map Database
by: Zhonglin Li, et al.
Published: (2020-10-01)

Discovery of Clioquinol and analogues as novel inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 infection, ACE2 and ACE2 - Spike protein interaction in vitro
by: Omonike A. Olaleye, et al.
Published: (2021-03-01)

Clinical Profile of COVID-19 in Children and Research Progress on Angiotensin-converting Enzyme 2: A Mini-review
by: Qian Gao, et al.
Published: (2020-10-01)

NOX-Dependent Signaling Dysregulation in Severe COVID-19: Clues to Effective Treatments
by: Simona Damiano, et al.
Published: (2020-12-01)

Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus
by: Yu-Huang Liao, et al.
Published: (2020-12-01)

Pathogenesis of COVID-19
by: A.E. Abaturov, et al.
Published: (2020-03-01)

Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Respiratory Infection
by: Abolaji Olagunju, et al.
Published: (2020-07-01)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020-06-01)

Male genital damage in COVID-19 patients: Are available data relevant?
by: Youssef Kharbach, et al.
Published: (2021-07-01)

Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
by: Omid Kooshkaki, et al.
Published: (2020-10-01)

In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression
by: Sanju Sinha, et al.
Published: (2020-07-01)

Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
by: Ming-Yieh Peng, et al.
Published: (2021-05-01)

The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19
by: Martina Di Maro, et al.
Published: (2021-05-01)

The Mechanisms and Animal Models of SARS-CoV-2 Infection
by: Wenrui Jia, et al.
Published: (2021-04-01)

Coronavirus disease and male fertility: a systematic review
by: Mobina Fathi, et al.
Published: (2021-08-01)

Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019
by: Lu Yang, et al.
Published: (2020-04-01)

COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management
by: Md. Farhad Hossain, et al.
Published: (2020-10-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Heart Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression Associated With Male Sex and Salt-Sensitive Hypertension in the Dahl Rat
by: Kirsti Ytrehus, et al.
Published: (2021-07-01)

ACE2 enhance viral infection or viral infection aggravate the underlying diseases
by: Shaolei Teng, et al.
Published: (2020-01-01)